Is Agenus AGEN stock recovering momentum Q4 2025 Profit Surprises PTGX Protagonist Therapeutics drops 255 after Q4 2025 EPS misses analyst estimates by a wide 385 margin Is Texas TVACW stock attractive at current levels Technical Strength 20260420 What metric defines Blue Moon BMM success this quarter Q4 2025 EPS Misses Estimates RPRX Royalty posts Q4 2025 87 percent EPS beat and 51 percent YoY revenue gain shares edge down Market Recap SP 500 dips slightly as volatility stays subdued in mixed trade First FIBK Stock Volume Drop Investor Interest 20260420 Cisco Systems CSCO AI Security Strategic Moves Signal Evolving Investment Thesis Amid Tech Infrastructure Expansion